MediciNova, Inc.
DE ˙ DB ˙ US58468P2065
DIESES SYMBOL IST NICHT MEHR AKTIV
1.859,00 € ↑5,00 (0,27%)
2021-12-19
AKTIENPREIS
SecurityDE:RMN / MediciNova, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership1,127,922 shares
Ownership 2.30%
BlackRock, Inc. ownership in RMN / MediciNova, Inc.

2021-07-12 - BlackRock, Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,127,922 shares of MediciNova, Inc. (DE:RMN). This represents 2.3 percent ownership of the company. In their previous filing dated 2021-01-29 , BlackRock, Inc. had reported owning 3,313,971 shares, indicating a decrease of -65.96 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2021-07-12 2021-07-12 13G/A 3,313,971 1,127,922 -65.96 2.30 -68.92
2021-01-29 2021-01-29 13G/A 2,835,590 3,313,971 16.87 7.40 13.85
2020-02-05 2020-02-05 13G/A 2,913,245 2,835,590 -2.67 6.50 -7.14
2019-02-08 2019-02-08 13G 2,913,245 2,913,245 0.00 7.00 0.00
2019-02-07 2019-02-07 13G 1,711,194 2,913,245 70.25 7.00 48.94
2018-01-09 2018-01-09 13G/A 1,974,411 1,711,194 -13.33 4.70 -17.54
2017-01-30 2017-01-30 13G 1,974,411 5.70

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F MEDICINOVA COM NEW 58468P206 705,954 984 0.14 967 4.77 0.0000
2026-02-12 2025-12-31 13F MEDICINOVA COM NEW 58468P206 704,970 6,003 0.86 924 4.06 0.0000
2025-11-12 2025-09-30 13F MEDICINOVA COM NEW 58468P206 698,967 3,252 0.47 888 -2.63 0.0000
2025-08-12 2025-06-30 13F MEDICINOVA COM NEW 58468P206 695,715 -4,626 -0.66 911 -10.86 0.0000
2025-05-02 2025-03-31 13F MEDICINOVA COM NEW 58468P206 700,341 -1,450 -0.21 1,022 -30.62 0.0000
2025-02-07 2024-12-31 13F MEDICINOVA COM NEW 58468P206 701,791 1,213 0.17 1,474 0.14 0.0000
2024-11-13 2024-09-30 13F MEDICINOVA COM NEW 58468P206 700,578 5,635 0.81 1,471 47.10 0.0000
2024-08-13 2024-06-30 13F MEDICINOVA COM NEW 58468P206 694,943 -477 -0.07 1,001 -0.79 0.0000
2024-05-10 2024-03-31 13F MEDICINOVA COM NEW 58468P206 695,420 -4,222 -0.60 1,008 -3.91 0.0000
2024-02-13 2023-12-31 13F MEDICINOVA COM NEW 58468P206 699,642 4,045 0.58 1,049 -27.80 0.0000
2023-11-13 2023-09-30 13F MEDICINOVA COM NEW 58468P206 695,597 -35,772 -4.89 1,454 -13.61 0.0000
2023-08-11 2023-06-30 13F MEDICINOVA COM NEW 58468P206 731,369 16,488 2.31 1,682 8.94 0.0000
2023-05-12 2023-03-31 13F MEDICINOVA COM NEW 58468P206 714,881 3,099 0.44 1,544 5.83 0.0000
2023-02-13 2022-12-31 13F MEDICINOVA COM NEW 58468P206 711,782 1,127 0.16 1,459 -5.38 0.0000
2022-11-14 2022-09-30 13F MEDICINOVA COM NEW 58468P206 710,655 -4,708 -0.66 1,542 -14.85 0.0001
2022-08-12 2022-06-30 13F MEDICINOVA COM NEW 58468P206 715,363 -6,491 -0.90 1,811 -6.07 0.0001
2022-05-12 2022-03-31 13F MEDICINOVA COM NEW 58468P206 721,854 -10,038 -1.37 1,928 -1.68 0.0001
2022-02-10 2021-12-31 13F MEDICINOVA COM NEW 58468P206 731,892 -414,078 -36.13 1,961 -54.86 0.0000
2021-11-09 2021-09-30 13F MEDICINOVA COM NEW 58468P206 1,145,970 18,048 1.60 4,344 -9.39 0.0001
2021-08-11 2021-06-30 13F MEDICINOVA COM NEW 58468P206 1,127,922 -2,259,671 -66.70 4,794 -71.98 0.0001
2021-05-07 2021-03-31 13F MEDICINOVA COM NEW 58468P206 3,387,593 73,622 2.22 17,107 -1.87 0.0005
2021-02-05 2020-12-31 13F MEDICINOVA COM NEW 58468P206 3,313,971 471,747 16.60 17,433 17.05 0.0006
2020-11-06 2020-09-30 13F MEDICINOVA COM NEW 58468P206 2,842,224 -21,451 -0.75 14,894 -4.04 0.0005
2020-08-14 2020-06-30 13F MEDICINOVA COM NEW 58468P206 2,863,675 35,954 1.27 15,521 47.57 0.0006
2020-05-01 2020-03-31 13F MEDICINOVA COM NEW 58468P206 2,827,721 -7,869 -0.28 10,518 -44.97 0.0005
2020-02-13 2019-12-31 13F MEDICINOVA COM NEW 58468P206 2,835,590 -375,349 -11.69 19,113 -25.18 0.0007
2019-11-08 2019-09-30 13F MEDICINOVA COM NEW 58468P206 3,210,939 75,628 2.41 25,544 -15.40 0.0011
2019-08-22 2019-06-30 13F/A-1 MEDICINOVA COM NEW 58468P206 3,135,311 326,947 11.64 30,194 29.84 0.0013
2019-08-13 2019-06-30 13F MEDICINOVA COM NEW 58468P206 3,135,311 326,947 30,194
2019-05-09 2019-03-31 13F MEDICINOVA COM NEW 58468P206 2,808,364 -104,881 -3.60 23,254 -2.30 0.0010
2019-02-08 2018-12-31 13F MEDICINOVA COM NEW 58468P206 2,913,245 504,452 20.94 23,801 -20.88 0.0012
2018-11-09 2018-09-30 13F MEDICINOVA COM NEW 58468P206 2,408,793 33,377 1.41 30,084 59.10 0.0013
2018-08-09 2018-06-30 13F MEDICINOVA COM NEW 58468P206 2,375,416 222,277 10.32 18,909 -14.07 0.0009
2018-05-09 2018-03-31 13F MEDICINOVA COM NEW 58468P206 2,153,139 441,945 25.83 22,005 98.74 0.0011
2018-02-09 2017-12-31 13F MEDICINOVA COM NEW 58468P206 1,711,194 -464,991 -21.37 11,072 -20.13 0.0005
2017-11-14 2017-09-30 13F MEDICINOVA COM NEW 58468P206 2,176,185 68,726 3.26 13,862 25.04 0.0007
2017-08-10 2017-06-30 13F MEDICINOVA COM NEW 58468P206 2,107,459 142,575 7.26 11,086 -5.80 0.0006
2017-05-12 2017-03-31 13F MEDICINOVA COM NEW 58468P206 1,964,884 1,963,764 175,336.07 11,769 168,028.57 0.0006
2017-02-10 2016-12-31 13F MEDICINOVA COM NEW 58468P206 1,120 0 0.00 7 -12.50 0.0000
2016-11-08 2016-09-30 13F MEDICINOVA COM NEW 58468P206 1,120 0 0.00 8 0.00 0.0000
2016-08-10 2016-06-30 13F MEDICINOVA COM NEW 58468P206 1,120 1,120 8 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.